Publications by authors named "Daniel Nagore"

Claim this Profile
C
Comparison between monotest and traditional batch-based ELISA assays for therapeutic drug monitoring of infliximab and adalimumab levels and anti-drug antibodies.
Mikel Moneo, Ainhoa Ruiz Del Agua, Begoña Ruiz-Argüello, Noelia Rapun, Daniel Nagore

Clin Chem Lab Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study.
Sarah Fischer, Moritz Donhauser, Sarah Cohnen, Konstantin Fietkau, Marcel Vetter, Daniel Nagore

Therap Adv Gastroenterol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial.
Catalina Gómez-Arango, Inigo Gorostiza, Eduardo Úcar, Maria Luz García-Vivar, Clara Eugenia Pérez, Daniel Nagore

Rheumatol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab.
Sarah Fischer, Sarah Cohnen, Entcho Klenske, Heike Schmitt, Francesco Vitali, Daniel Nagore

Therap Adv Gastroenterol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis.
Ingo Ganzleben, Carol Geppert, Lourdes Osaba, Simon Hirschmann, Andreas Nägel, Daniel Nagore

Therap Adv Gastroenterol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy.
Ingo Ganzleben, Simon Hirschmann, Julia Köhler, Florian S Fuchs, Ralf J Rieker, Daniel Nagore

Am J Gastroenterol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal concentration range of ustekinumab in patients with plaque-type psoriasis.
Sergio Martín-González, Peru Urigoitia-Ugalde, Jesús Careaga, Daniel Nagore, Rosaura Navarro

J Am Acad Dermatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn's Disease.
Entcho Klenske, Lourdes Osaba, Daniel Nagore, Timo Rath, Markus F Neurath

J Crohns Colitis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic pattern of implantative human endometrial fluid in in vitro fertilization cycles.
Roberto Matorras, Sara Quevedo, Blanca Corral, Begoña Prieto, Antonia Exposito, Daniel Nagore

Arch Gynecol Obstet· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease.
Gionata Fiorino, M Begoña Ruiz-Argüello, Ainara Maguregui, Daniel Nagore, Carmen Correale

Inflamm Bowel Dis· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies to infliximab in Remicade-treated rheumatic patients show identical reactivity towards biosimilars.
M Begoña Ruiz-Argüello, Ainara Maguregui, Ainhoa Ruiz Del Agua, Dora Pascual-Salcedo, Ana Martínez-Feito, Daniel Nagore

Ann Rheum Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison study of two commercially available methods for the determination of golimumab and anti-golimumab antibody levels in patients with rheumatic diseases.
Sergio Martín, Ainhoa Ruiz del Agua, Nerea Torres, Dora Pascual-Salcedo, Chamaida Plasencia, Daniel Nagore

Clin Chem Lab Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new biomarker panel in bronchoalveolar lavage for an improved lung cancer diagnosis.
María Uribarri, Itsaso Hormaeche, Rafael Zalacain, Guillermo Lopez-Vivanco, Antonio Martinez, Daniel Nagore

J Thorac Oncol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels.
Begoña Ruiz-Argüello, Ainhoa Ruiz del Agua, Nerea Torres, Alberto Monasterio, Antonio Martínez, Daniel Nagore

Clin Chem Lab Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab.
Chamaida Plasencia, Dora Pascual-Salcedo, Laura Nuño, Gema Bonilla, Alejandro Villalba, Daniel Nagore

Ann Rheum Dis· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis.
Dora Pascual-Salcedo, Chamaida Plasencia, Susana Ramiro, Laura Nuño, Gema Bonilla, Daniel Nagore

Rheumatology (Oxford)· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug efflux pump MdtBC of Escherichia coli is active only as a B2C heterotrimer.
Hong-Suk Kim, Daniel Nagore, Hiroshi Nikaido

J Bacteriol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive proteomic analysis of human endometrial fluid aspirate.
Juan Casado-Vela, Eva Rodriguez-Suarez, Ibon Iloro, Amagoia Ametzazurra, Nere Alkorta, Daniel Nagore

J Proteome Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular diagnosis of Theileria and Babesia species infecting cattle in Northern Spain using reverse line blot macroarrays.
Josune García-Sanmartín, Daniel Nagore, Ana L García-Pérez, Ramón A Juste, Ana Hurtado

BMC Vet Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The nitrate/nitrite ABC transporter of Phormidium laminosum: phosphorylation state of NrtA is not involved in its substrate binding activity.
Daniel Nagore, Begoña Sanz, Javier Soria, Marta Llarena, María J Llama

Biochim Biophys Acta· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and identification of equine Theileria and Babesia species by reverse line blotting: epidemiological survey and phylogenetic analysis.
Daniel Nagore, Josune García-Sanmartín, Ana L García-Pérez, Ramón A Juste, Ana Hurtado

Vet Parasitol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, genetic diversity and prevalence of Theileria and Babesia species in a sheep population from Northern Spain.
Daniel Nagore, Josune García-Sanmartín, Ana L García-Pérez, Ramón A Juste, Ana Hurtado

Int J Parasitol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the N-terminal domain of NrtC, the ATP-binding subunit of ABC-type nitrate transporter of the cyanobacterium Phormidium laminosum.
Daniel Nagore, Marta Llarena, María J Llama, Juan L Serra

Biochim Biophys Acta· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis